Jaipur-based healthtech startup Aignosis has raised Rs 4 crore in a seed funding round led by Antler and Nikhil Kamath. The round also saw participation from investors including Varun Dua and IIMA Ventures.
The startup will use the fresh funding to expand its AI-assisted autism and developmental screening platform across India. The company is now moving from building and testing its technology to bringing it into more public and private healthcare networks.
Founded by Raksheet Jain and Divyansh Mangal, Aignosis had previously raised its first funding round in 2024 from investors including Rajneesh Bhandari and Amit Jain.
Making Autism Screening More Accessible
Raksheet Jain, Co-founder of Aignosis, said the latest funding marks a new phase for the company, moving from technology development and validation to taking its solution into the healthcare system at a larger scale.
The startup wants to make autism screening easier to access, improve the referral process and build a model that can work across both government and private healthcare settings.
How Aignosis' AI Screening Works
Aignosis has developed a screening system designed to help identify children who may need further clinical assessment for autism and other developmental concerns.
The system works using a standard laptop and webcam and is designed for children between 16 months and nine years old.
During a short video session involving nine stimulus modules, computer vision technology studies different behavioural signals, including a child's gaze, response to their name, and reaction to facial expressions.
The technology then creates a risk report showing whether the child may require further clinical assessment.
Importantly, the platform does not provide a medical diagnosis. It is designed as a screening tool to help identify children who may need additional evaluation.
Aignosis has completed the regulatory process with India's Central Drugs Standard Control Organisation (CDSCO) and received Class B certification for its screening technology.
From Government Centres to Schools
Aignosis was incubated at IIMA Ventures and was also selected for Google's 2025 Google for Startups Accelerator: AI First programme.
Google selected Aignosis among 20 startups from more than 1,600 applications.
The startup was also selected for BFI VK Connect and took part in a three-week immersion programme in Europe.
The company mainly operates through a Clinic-in-Clinic model, where its screening technology is used by paediatricians rather than being sold as a standalone device.
This allows doctors to include developmental screening in their regular practice and identify children who may need further assessment or referral.
Aignosis is currently deployed across more than 20 government primary healthcare centres in Rajasthan.
The startup has also partnered with Mankind Pharma, whose medical representatives are supporting screening camps with paediatricians across India.
It is also starting operations with Apollo SHINE Foundation across around 125 schools.
Nikhil Kamath Backs the Approach
Investor Nikhil Kamath said much of India's healthcare innovation is built for people at the top of the income pyramid and often does not reach smaller towns and government healthcare facilities.
He said Aignosis is taking a different approach by starting with government health centres and smaller clinics instead of focusing only on private hospitals in major cities.
Target of 1 Lakh Screenings
Aignosis has completed more than 8,000 screenings so far and aims to take that number to at least 1 lakh screenings by the end of FY2026-27.
The startup is now preparing to expand into Punjab, the National Capital Region, Haryana, Tamil Nadu, Jharkhand, Karnataka and Maharashtra.
Aignosis plans to use its experience in Rajasthan as a model for wider government adoption while also expanding its screening and referral network across private healthcare.
With fresh funding and a growing network of clinics, health centres and schools, the startup is now looking to make early developmental screening more accessible to families across India.
